Navigation Links
Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing
Date:2/10/2010

NEW YORK, Feb. 10 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease ("AD"), announced today that several of its significant shareholders (the "Interested Shareholders") have agreed in principle to provide interim funding to the Company and assist the Company in its efforts to restructure its balance sheet.  The Company has initiated discussions with the Interested Shareholders regarding a potential equity financing to fund operations for a longer period than that covered by the interim funding. The contemplated transactions are subject to negotiation and execution of definitive agreements.

Appointment of New Directors

In connection with the contemplated financings, the Interested Shareholders will be given the right to appoint three new members to a newly constituted Board of Directors of the Company. Recently, the Company disclosed that its former independent directors resigned their positions because of a lack of funding to pay for directors and officers liability insurance. The Interested Investors intend to nominate suitable candidates to fill the Board vacancies shortly. The Company intends to seek the approval of its shareholders to a resolution amending the Company's certificate of incorporation to reduce the number of seats on the Board of Directors to five members.

Management Changes

Dr. Daniel Chain has agreed to resign from his position as Chief Executive Officer and assume the position of Chief Scientific Officer so that he may focus his time on advancing the Company's pipeline programs. He will remain Chairman of the Board of Directors. Elliot Maza will remain President and CFO and a m
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
2. BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool
3. Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property
4. Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
5. Veteran Intellectual Property Team Joins Brown Rudnick
6. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
7. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
8. Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property
9. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
10. Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers
11. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Chester, OH (PRWEB) November 25, 2014 ... Holdings, has joined the Graphel Carbon Products team as ... in sales, marketing, and customer service for the graphite ... add Miles to our team,” stated Dave Trinkley, VP ... “His wide range of experience in the graphite ...
(Date:11/26/2014)... , 25 novembre 2014 Theravalues Corporation est ... le marché européen au salon Hi Europe 2014 ... ). Curcumine la plus biodisponible ... amorphe (non-cristalline) à des ingrédients approuvés par les ... pigment jaune présent dans la racine de curcuma ...
(Date:11/24/2014)... N.J. , Nov. 24, 2014  IGI Laboratories, ... based specialty generic pharmaceutical company, today announced ... (ANDA) to the U.S. Food and Drug Administration (FDA), ... in 2014 to seven, with eighteen submissions now pending ... , President and CEO of the Company, commented, "Our ...
(Date:11/24/2014)...   First published articles now available ... , a world-leading provider of scientific, technical and medical information ... the latest title in the Current Opinion journal series ... . Current Opinion in Food ... keep up-to-date with the expanding volume of information published in ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3IGI Laboratories, Inc. Announces ANDA Submission 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... child waits for Christmas. Today, PalmOne introduces the ... I buy?" conundrum. , ,I saw the new Treo six weeks ... (Yes, even I take a break from the schmoozing to sneak ... fell in love. This newest handheld communicator takes everything that ...
... is rapidly coming to a close, the fourth quarter represents a ... states. Witness the more important of these events: , , ... lot of biotech activities! This is a good sign and bodes ... annual meeting in Chicago. Its also an indicator that biotech is ...
... Madison, Wis. Angel and venture capitalists looking ... on a few business strategies that make some life-sciences ... panel of experts who spoke at the Wisconsin ... 26. The trade association attracted 300 industry representatives to ...
Cached Biology Technology:Christmas comes early with Treo 650 2Christmas comes early with Treo 650 3Furious pace of Midwest biotech events marks progress 2Furious pace of Midwest biotech events marks progress 3Local biotech startups must compete nationally for investors attention 2Local biotech startups must compete nationally for investors attention 3
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/18/2014)... 18, 2014  The Secure Identity & Biometrics ... jointly announce the formation of The Airport Entry ... Identity and Biometric Entry and Exit Solutions ... official support from BORDERPOL, the international non-profit organization ... provide expertise regarding border security, traveler and migration ...
(Date:11/15/2014)... YORK , Nov. 13, 2014  While we may ... technology Doctor McCoy used in "Star Trek" to gain instant ... tools designed to work with smartphones and tablets for monitoring ... of the healthcare world. This may seem a tad Orwellian ... ready to adopt some of these technological opportunities into their ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... This press release is available in German ... a few nanometers and possess a high luminous potential. Scientists ... in manufacturing silicon-based light-emitting diodes (SiLEDs). They are free of ... team of chemists, materials researchers, nanoscientists, and opto-electronic experts presents ...
... National Science Foundation (NSF) announced the latest round of ... effort. I-Corps is a public-private partnership to help develop ... The three awards, totaling $11,239,921, went to three consortia ... support regional needs for innovation education, infrastructure and research. ...
... University of California, Berkeley, UC San Francisco and Stanford ... commercializing university research and fostering innovation locally and nationally, ... National Science Foundation (NSF). The "I-Corps Node: NSF ... new Innovation Corps (or I-Corps) Nodes that the NSF ...
Cached Biology News:Light from silicon nanocrystal LEDs 2New grants to innovation corps 'nodes' further enhance public-private partnership 2New grants to innovation corps 'nodes' further enhance public-private partnership 3UC Berkeley, UCSF and Stanford join forces to help commercialize university innovations 2UC Berkeley, UCSF and Stanford join forces to help commercialize university innovations 3
Purified anti-SOCS3...
Tumor Suppressor Sampler Kit 10 mu g each...
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice...
Umbilical cord blood eosinophils, For immunohistochemistry (IHC)...
Biology Products: